INHIBIKASE THERAPEUTICS INC (IKT) Institutional Ownership and Insiders Activity

INHIBIKASE THERAPEUTICS INC (IKT) is widely held by institutional investors, with 106 firms reporting positions valued at approximately $238.20M based on SEC Form 13F filings for the quarter ended June 30, 2026.

Sands Capital Alternatives, Llc is the largest disclosed holder, reporting approximately $26.43M in IKT holdings in its latest filing.

Recent insider activity includes 2 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.